FDA Import Refusal 799-3316954-3/21/1 — NIPRO JMI PHARMA LTD
The FDA refused shipment 799-3316954-3/21/1 from NIPRO JMI PHARMA LTD (Bangladesh) on Oct 2, 2024. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75
Refusal details
- Date
- Oct 2, 2024
- Country
- Bangladesh
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75